Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine

Minoru Kawamura, Irwin J. Kopin, Peter F Kador, Sanai Sato, Olga Tjurmina, Graeme Eisenhofer

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

After norepinephrine (NE) is deaminated by monoamine oxidase (MAO), the aldehyde formed is either metabolized to 3,4-dihydroxymandelic acid (DHMA) by aldehyde dehydrogenase or is converted to 3,4-dihydroxyphenylglycol (DHPG) by aldehyde or aldose reductase. The present study examined the effects of inhibition of aldehyde and aldose reductase on production of DHPG and DHMA in rats. Mean (± S.E.) baseline plasma concentrations of DHPG (4.73 ± 0.21 pmol/ml) were 60-fold higher than those of DHMA 0.08 ± 0.01 pmol/ml). Inhibition of aldose and aldehyde reductase reduced plasma DHPG concentrations to 1.88 ± 0.14 pmol/ml and increased plasma DHMA to 4.43 ± 0.29 pmol/ml; additional inhibition of MAO reduced plasma DHPG to 0.16 ± 0.06 pmol/ml and DHMA to 0.19 ± 0.02 pmol/ml. Inhibition of aldehyde and aldose reductase also increased brain tissue levels of DHMA from 8 ± 2 to 384 ± 47 pmol/g and decreased levels of DHPG from 70 ± 9 to 44 ± 5 pmol/g. The results show that DHMA is normally a minor metabolite of NE, but becomes a major metabolite after aldehyde/aldose reductase inhibition.

Original languageEnglish (US)
Pages (from-to)145-148
Number of pages4
JournalJournal of the Autonomic Nervous System
Volume66
Issue number3
DOIs
StatePublished - Oct 13 1997

Fingerprint

Aldehyde Reductase
Norepinephrine
Monoamine Oxidase
Aldehyde Dehydrogenase
3,4-dihydroxymandelic acid
Aldehydes

Keywords

  • 3,4-Dihydroxymandelic acid
  • 3,4-Dihydroxyphenylglycol
  • Aldehyde reductase
  • Monoamine oxidase
  • Norepinephrine
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology
  • Clinical Neurology

Cite this

Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine. / Kawamura, Minoru; Kopin, Irwin J.; Kador, Peter F; Sato, Sanai; Tjurmina, Olga; Eisenhofer, Graeme.

In: Journal of the Autonomic Nervous System, Vol. 66, No. 3, 13.10.1997, p. 145-148.

Research output: Contribution to journalArticle

Kawamura, Minoru ; Kopin, Irwin J. ; Kador, Peter F ; Sato, Sanai ; Tjurmina, Olga ; Eisenhofer, Graeme. / Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine. In: Journal of the Autonomic Nervous System. 1997 ; Vol. 66, No. 3. pp. 145-148.
@article{210f9ea660f64c43b8bc8a4fc7782389,
title = "Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine",
abstract = "After norepinephrine (NE) is deaminated by monoamine oxidase (MAO), the aldehyde formed is either metabolized to 3,4-dihydroxymandelic acid (DHMA) by aldehyde dehydrogenase or is converted to 3,4-dihydroxyphenylglycol (DHPG) by aldehyde or aldose reductase. The present study examined the effects of inhibition of aldehyde and aldose reductase on production of DHPG and DHMA in rats. Mean (± S.E.) baseline plasma concentrations of DHPG (4.73 ± 0.21 pmol/ml) were 60-fold higher than those of DHMA 0.08 ± 0.01 pmol/ml). Inhibition of aldose and aldehyde reductase reduced plasma DHPG concentrations to 1.88 ± 0.14 pmol/ml and increased plasma DHMA to 4.43 ± 0.29 pmol/ml; additional inhibition of MAO reduced plasma DHPG to 0.16 ± 0.06 pmol/ml and DHMA to 0.19 ± 0.02 pmol/ml. Inhibition of aldehyde and aldose reductase also increased brain tissue levels of DHMA from 8 ± 2 to 384 ± 47 pmol/g and decreased levels of DHPG from 70 ± 9 to 44 ± 5 pmol/g. The results show that DHMA is normally a minor metabolite of NE, but becomes a major metabolite after aldehyde/aldose reductase inhibition.",
keywords = "3,4-Dihydroxymandelic acid, 3,4-Dihydroxyphenylglycol, Aldehyde reductase, Monoamine oxidase, Norepinephrine, Sympathetic nervous system",
author = "Minoru Kawamura and Kopin, {Irwin J.} and Kador, {Peter F} and Sanai Sato and Olga Tjurmina and Graeme Eisenhofer",
year = "1997",
month = "10",
day = "13",
doi = "10.1016/S0165-1838(97)00086-6",
language = "English (US)",
volume = "66",
pages = "145--148",
journal = "Autonomic Neuroscience: Basic and Clinical",
issn = "1566-0702",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine

AU - Kawamura, Minoru

AU - Kopin, Irwin J.

AU - Kador, Peter F

AU - Sato, Sanai

AU - Tjurmina, Olga

AU - Eisenhofer, Graeme

PY - 1997/10/13

Y1 - 1997/10/13

N2 - After norepinephrine (NE) is deaminated by monoamine oxidase (MAO), the aldehyde formed is either metabolized to 3,4-dihydroxymandelic acid (DHMA) by aldehyde dehydrogenase or is converted to 3,4-dihydroxyphenylglycol (DHPG) by aldehyde or aldose reductase. The present study examined the effects of inhibition of aldehyde and aldose reductase on production of DHPG and DHMA in rats. Mean (± S.E.) baseline plasma concentrations of DHPG (4.73 ± 0.21 pmol/ml) were 60-fold higher than those of DHMA 0.08 ± 0.01 pmol/ml). Inhibition of aldose and aldehyde reductase reduced plasma DHPG concentrations to 1.88 ± 0.14 pmol/ml and increased plasma DHMA to 4.43 ± 0.29 pmol/ml; additional inhibition of MAO reduced plasma DHPG to 0.16 ± 0.06 pmol/ml and DHMA to 0.19 ± 0.02 pmol/ml. Inhibition of aldehyde and aldose reductase also increased brain tissue levels of DHMA from 8 ± 2 to 384 ± 47 pmol/g and decreased levels of DHPG from 70 ± 9 to 44 ± 5 pmol/g. The results show that DHMA is normally a minor metabolite of NE, but becomes a major metabolite after aldehyde/aldose reductase inhibition.

AB - After norepinephrine (NE) is deaminated by monoamine oxidase (MAO), the aldehyde formed is either metabolized to 3,4-dihydroxymandelic acid (DHMA) by aldehyde dehydrogenase or is converted to 3,4-dihydroxyphenylglycol (DHPG) by aldehyde or aldose reductase. The present study examined the effects of inhibition of aldehyde and aldose reductase on production of DHPG and DHMA in rats. Mean (± S.E.) baseline plasma concentrations of DHPG (4.73 ± 0.21 pmol/ml) were 60-fold higher than those of DHMA 0.08 ± 0.01 pmol/ml). Inhibition of aldose and aldehyde reductase reduced plasma DHPG concentrations to 1.88 ± 0.14 pmol/ml and increased plasma DHMA to 4.43 ± 0.29 pmol/ml; additional inhibition of MAO reduced plasma DHPG to 0.16 ± 0.06 pmol/ml and DHMA to 0.19 ± 0.02 pmol/ml. Inhibition of aldehyde and aldose reductase also increased brain tissue levels of DHMA from 8 ± 2 to 384 ± 47 pmol/g and decreased levels of DHPG from 70 ± 9 to 44 ± 5 pmol/g. The results show that DHMA is normally a minor metabolite of NE, but becomes a major metabolite after aldehyde/aldose reductase inhibition.

KW - 3,4-Dihydroxymandelic acid

KW - 3,4-Dihydroxyphenylglycol

KW - Aldehyde reductase

KW - Monoamine oxidase

KW - Norepinephrine

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0030667647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030667647&partnerID=8YFLogxK

U2 - 10.1016/S0165-1838(97)00086-6

DO - 10.1016/S0165-1838(97)00086-6

M3 - Article

VL - 66

SP - 145

EP - 148

JO - Autonomic Neuroscience: Basic and Clinical

JF - Autonomic Neuroscience: Basic and Clinical

SN - 1566-0702

IS - 3

ER -